Lab members
Meet our talented team of postdoctoral researchers, PhD students, technicians and associate members at the Immune Regulation and Tumour Immunotherapy Lab, led by Professor Sergio Quezada.

Postdoctoral Researchers

Postdoctoral Researcher

Postdoctoral Researcher

Dr Maria Vila de Mucha
Postdoctoral Researcher (in collaboration with the Jenner Lab)
Investigates the role of CD4+ T cells in anti-tumour immunity, with a focus on how the differentiation of cytotoxic CD4+ T cells is regulated on an epigenetic and transcriptional level in tumours.

Dr Dimitrios Garyfallos
Postdoctoral Researcher (in collaboration with the Hiley Lab)

Postdoctoral Researcher
Studies the immune landscape in poorly-infiltrated mouse models following Treg depletion and inoculation with a cancer vaccine. Also interested in exploring the potential mechanisms underlying tumour resistance to the combinatorial therapy.

Dr Chen Qing
Postdoctoral Researcher
Studies the immune landscape in poorly-infiltrated mouse models following Treg depletion and inoculation with a cancer vaccine. Also interested in exploring the potential mechanisms underlying tumour resistance to the combinatorial therapy.
PhD Students

PhD Student

Ms Despoina Karagianni
PhD Student / Lab Technician
Develops a loss-of-function pipeline with in vitro and in vivo models of tumour reactivity using CRISPR/Cas9 methodology in order to identify targetable pathways that enhance T cell activation in the context of non-small cell lung cancer (NSCLC). Other responsibilities include assisting with the engineering of bispecific antibodies against Fcγ receptors, managing the lab and social media. Follow on LinkedIn.

PhD Student

Mr Kane Foster
PhD Student (in collaboration with the Yong Lab)
Explores how changes in T cell function can contribute to the progression of pre-cancerous conditions such as smouldering multiple myeloma. Investigates T cell responses at the single cell level by analysing RNA-seq, TCR-seq and flow/mass cytometry data using machine learning and computational statistics. Follow on X.

PhD Student (in collaboration with the Litchfield Lab)
Develops the tumour fragment platform as an ex vivo technique and investigates its ability to recapitulate the complexity of tumour architecture and the microenvironment. Also interested in the immunotherapeutic response of the tumour fragment platform to fs-indel derived neoantigens escaping from the nonsense-mediated decay (NMD) pathway. Follow on LinkedIn.

Mr Yuta Nagano
PhD Student (in collaboration with the Chain Lab)

Ms Bethany Hudson-Lund
PhD Student
Technicians

Senior Explant and PDX Platform Manager
Established and runs a patient-derived immune xenograft (PDiX) core as part of the Cancer Research UK City of London (CRUK CoL) Centre. This includes writing SOPs, establishing tissue biobanks and collaborating with other research groups. Other responsibilities including managing lab admin, social media, and members of the group. Follow on LinkedIn.

Ms Supreet Kaur Bola
Technician
Handles the processing, storage and retrieval of all clinical samples for immunological analysis ensuring compliance with the Human Tissue Act and maintaining Good Clinical Lab Practice. Other responsibilities include managing lab social media. Follow on LinkedIn.

Mr Gerasimos Mastrokalos
Research Technician

Ms Yasmin Morris
Senior Research Technician

Ms Angela Dwornik
Lab Technician

Mr Aniruddh Tyagi
Research Technician
Responsible for the development and implementation of the Biotherapeutics pipeline, with a heavy focus on the design, development and purification of Bi- and Tri-specific antibodies. Follow on LinkedIn.

Ms Varshaa Anantharam
Research Technician
Associate Members

Ms Ayse Akarca
Research Fellow
Provides a service for multiplex immunolabelling to pharmaceutical companies and clinical trials. Focuses on tissue-based arrays and image analysis.

Immune Regulation and Tumour Immunotherapy
The Immune Regulation and Tumour Immunotherapy Lab at the UCL Cancer Institute aims to investigate the interplay between the immune system and cancer throughout tumour progression and immunotherapy.